MGMT promoter methylation and field defect in sporadic colorectal cancer

Journal of the National Cancer Institute

Volumn 97, Issue 18, 2005, Pages 1330-1338

  Shen, Lanlan ^a   Kondo, Yutaka ^a   Rosner, Gary L ^a   Xiao, Lianchun ^a   Hernandez, Natalie Supunpong ^a   Vilaythong, Jill ^a   Houlihan, P Scott ^a   Krouse, Robert S ^b   Prasad, Anil R ^b   Einspahr, Janine G ^c   Buckmeier, Julie ^c   Alberts, David S ^c   Hamilton, Stanley R ^a   Issa, Jean Pierre J ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; HYDROGEN SULFITE; KRAS2 PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN P53; SULFITE; TUMOR MARKER;

ADULT; AGED; ALLELE; ARTICLE; CANCER PATIENT; CANCER RISK; COLON MUCOSA; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE MARKER; DNA METHYLATION; EPIGENETICS; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; ONCOGENE K RAS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SEQUENCE ANALYSIS; STATISTICAL ANALYSIS; COLORECTAL TUMOR; DNA SEQUENCE; ENZYMOLOGY; GENE SILENCING; GENETIC EPIGENESIS; GENETICS; INTESTINE MUCOSA; METHODOLOGY; MUTATION; PATHOLOGY; POLYMERASE CHAIN REACTION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TUMOR CELL LINE;

CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DNA METHYLATION; EPIGENESIS, GENETIC; GENE SILENCING; HUMANS; INTESTINAL MUCOSA; MUTATION; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; SULFITES; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 25144518262     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dji275     Document Type: Article

References (29)

1. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter's concept of field cancerization: Evidence and clinical implications. Cancer Res 2003;63:1727-30.
2. Kim ES, Hong WK, Khuri FR. Chemoprevention of aerodigestive tract cancers. Annu Rev Med 2002;53:223-43.
3. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994;7:536-40.
4. Issa JP. Epigenetic variation and human disease. J Nutr 2002;132: 2388S-92S.
5. Pegg AE. Repair of O(6)-alkylguanine by alkyltransferases. Mutat Res 2000;462:83-100.
6. Kaina B, Ochs K, Grosch S, Fritz G, Lips J, Tomicic M, et al. BER, MGMT, and MMR in defense against alkylation-induced genotoxicity and apoptosis. Prog Nucleic Acid Res Mol Biol 2001;68:41-54.
7. Povey AC, Badawi AF, Cooper DP, Hall CN, Harrison KL, Jackson PE, et al. DNA alkylation and repair in the large bowel: Animal and human studies. J Nutr 2002;132:3518S-21S.
8. Qian X, von Wronski MA, Brent TP. Localization of methylation sites in the human O6-methylguanine-DNA methyltransferase promoter: Correlation with gene suppression. Carcinogenesis 1995;16:1385-90.
9. Costello JF, Futscher BW, Tano K, Graunke DM, Pieper RO. Graded methylation in the promoter and body of the O6-methylguanine DNA methyltransferase (mgmt) gene correlates with mgmt expression in human glioma cells. J Biol Chem 1994;269:17228-37.
10. Esteller M, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Watkins DN, et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res 2000;60: 2368-71.
11. Whitehall VL, Walsh MD, Young J, Leggett BA, Jass JR. Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res 2001;61:827-30.
12. Toyota M, Ohe-Toyota M, Ahuja N, Issa JP. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proc Natl Acad Sci U S A 2000;97:710-5.
13. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG Island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999;96:8681-6.
14. Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994;22:2990-7.
15. Cottrell SE, Laird PW. Sensitive detection of DNA methylation. Ann N Y Acad Sci 2003;983:120-30.
16. Ichii S, Takeda S, Horii A, Nakatsuru S, Miyoshi Y, Emi M, et al. Detailed analysis of genetic alterations in colorectal tumors from patients with and without familial adenomatous polyposis (FAP). Oncogene 1993;8:2399-405.
17. Brent TP, von Wronski M, Pegram CN, Bigner DD. Immunoaffinity purification of human O6-alkylguanine-DNA alkyltransferase using newly developed monoclonal antibodies. Cancer Res 1990;50:58-61.
18. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation - a fundamental aspect of neoplasia. Adv Cancer Res 1998;72:141-96.
19. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999;21:163-7.
20. Issa JP. The epigenetics of colorectal cancer. Ann N Y Acad Sci 2000;910:140-53.
21. Issa JP. CpG-island methylation in aging and cancer. Curr Top Microbiol Immunol 2000;249:101-18.
22. Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res 2002;62:2370-7.
23. Sidransky D. Emerging molecular markers of cancer. Nat Rev Cancer 2002;2:210-9.
24. Jass JR. Serrated route to colorectal cancer: Back street or super highway? J Pathol 2001;193:283-5.
25. Chan AO, Issa JP, Morris JS, Hamilton SR, Rashid A. Concordant CpG island methylation in hyperplastic polyposis. Am J Pathol 2002;160:529-36.
26. Margison GP, Povey AC, Kaina B, Santibanez Koref MF. Variability and regulation of O6-alkylguanine-DNA alkyltransferase. Carcinogenesis 2003;24:625-35.
27. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 1998;58:5489-94.
28. Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall TA. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 2001;61:3573-7.
29. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, et al. Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology 1997;112:594-642.